Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Sarcoidosis Occured after Treatment of Tuberculous Lymphadenitis

Lee HJ, Yoon SY, Han JM, An JH, Lee JJ, Choi CM, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Song JW

  • Tuberc Respir Dis.
  • 2011 May;70(5):433-437.
Sarcoidosis is a multisystemic disorder characterized by the presence of non-caseating granulomas in the involved organ. Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis and is characterized by granuloma...
A Case of Pulmonary Lymphangiomatosis

Jang EK, Kim CR, Choi CM, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Song JW

  • Tuberc Respir Dis.
  • 2011 May;70(5):428-432.
Pulmonary lymphangiomatosis is a rare disorder involving the entire intrathoracic lymphatic system from the mediastinum to the pleura. Pulmonary lymphangiomatosis mostly occurs in children and young adults without gender predilection....
Endobronchial Metastasis of Epithelioid Sarcoma

Kim SY, Lee JY, Lee YJ, Park SS, Koo HK, Lee SM, Yim JJ, Yang SC, Yoo CG, Han SK, Shim YS, Kim YW

  • Tuberc Respir Dis.
  • 2011 May;70(5):423-427.
Epithelioid sarcomas are rare soft tissue sarcomas with a high tumor grade and high local recurrence and metastasis rates. Although the lung is the most common site of metastasis, endobronchial...
Recent 10 Years' Trend Analysis of Inhaled Corticosteroids Prescription Rate and Severe Exacerbation Rate in Asthma Patients

Noh CS, Lee JS, Song JW, Kim TB, Kim NK, Cho YS, Lee SD, Moon HB, Oh YM

  • Tuberc Respir Dis.
  • 2011 May;70(5):416-422.
BACKGROUND: Inhaled corticosteroids (ICSs) are the most essential medication for asthma control. Many reports suggest that the usage of ICSs improves not only the control of asthma symptoms but also...
The Effect of Tissue Plasminogen Activator on TGF-beta1 Pre-Treated Human Mesothelial Cell Line

Lee J, Jeon SJ, Yoo YC, Kim JH, Lee YM, Kwon SJ, Son JW, Choi E, Na MJ

  • Tuberc Respir Dis.
  • 2011 May;70(5):405-415.
BACKGROUND: In an effort to find alternative therapeutic agents to prevent excessive fibrosis as a sequela to complicated parapneumonic effusion or empyema, we examined the effect of tissue plasminogen activator...
Pandemic Influenza A/H1N1 Viral Pneumonia without Co-Infection in Korea: Chest CT Findings

Son JS, Kim YH, Lee YK, Park SY, Choi CW, Park MJ, Yoo JH, Kang HM, Lee JH, Park B

  • Tuberc Respir Dis.
  • 2011 May;70(5):397-404.
BACKGROUND: To evaluate chest CT findings of pandemic influenza A/H1N1 pneumonia without co-infection. METHODS: Among 56 patients diagnosed with pandemic influenza A/H1N1 pneumonia, chest CT was obtained in 22 between October...
The Effect of Hyaluronan Treatment in Endotoxemic Rats

Rho BH, Kwon KY, Choi WI

  • Tuberc Respir Dis.
  • 2011 May;70(5):390-396.
BACKGROUND: Hyaluronan (HA) is an unbranched glycosaminoglycan. It has been proposed that HA acts as a vehicle for cytokines due to the strong negative charge on its surface. We hypothesized...
Issues on Safety of Long-Acting Muscarinic Antagonist

Lee YD, Cho Y, Han MS

  • Tuberc Respir Dis.
  • 2011 May;70(5):384-389.
The prevention of and the controlling of symptoms, reductions in the frequency of exacerbations, and disease severity are central to the pharmacologic therapy of chronic obstructive pulmonary disease (COPD). COPD...
Pneumonia in Immunocompromised Patients

Yoon HK

  • Tuberc Respir Dis.
  • 2011 May;70(5):371-383.
The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr